Related Experiment Videos

[Haemophilus influenzae meningitis. Review of 21 cases]

Insights

Ampicillin-resistant Haemophilus influenzae meningitis is increasing, with 38% resistance noted. Early treatment is crucial, as delayed care over 72 hours led to sequelae in patients.

Area of Science:

  • Infectious Diseases
  • Neurology
  • Microbiology

Background:

  • Haemophilus influenzae meningitis poses a significant public health challenge.
  • Emergence of antibiotic resistance in H. influenzae complicates treatment strategies.

Purpose of the Study:

  • To analyze trends in ampicillin resistance of H. influenzae causing meningitis.
  • To evaluate the impact of treatment delay on patient outcomes.
  • To recommend optimal therapeutic approaches for H. influenzae meningitis.

Main Methods:

  • Retrospective analysis of 21 H. influenzae meningitis cases over seven years.
  • Monitoring of ampicillin resistance rates in H. influenzae isolates from blood and cerebrospinal fluid (CSF).
  • Correlation of symptom duration before treatment with clinical outcomes and hospital stay.

Main Results:

  • Ampicillin resistance in H. influenzae meningitis rose to 33% in the last two years.
  • Overall resistance in blood or CSF isolates reached 38%.
  • Delayed treatment (over 72 hours) was associated with severe neurologic damage and prolonged hospital stays, with both patients experiencing sequelae.

Conclusions:

  • Chloramphenicol should be considered in empirical therapy for severe H. influenzae infections in this region due to rising ampicillin resistance.
  • Prompt diagnosis and treatment initiation are critical to prevent neurological damage and improve patient prognosis.
  • Continued surveillance of antibiotic resistance patterns is essential for effective H. influenzae meningitis management.

Related Concept Videos